[HTML][HTML] The world of protein acetylation
Acetylation is one of the major post-translational protein modifications in the cell, with
manifold effects on the protein level as well as on the metabolome level. The acetyl group …
manifold effects on the protein level as well as on the metabolome level. The acetyl group …
[HTML][HTML] Histone deacetylases and cancer
B Barneda-Zahonero, M Parra - Molecular oncology, 2012 - Elsevier
Reversible acetylation of histone and non-histone proteins is one of the most abundant post-
translational modifications in eukaryotic cells. Protein acetylation and deacetylation are …
translational modifications in eukaryotic cells. Protein acetylation and deacetylation are …
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of
small-molecule therapeutics acting through the regulation of the acetylation states of histone …
small-molecule therapeutics acting through the regulation of the acetylation states of histone …
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
O Khan, NB La Thangue - Immunology and cell biology, 2012 - Wiley Online Library
Reversible acetylation mediated by histone deacetylases (HDACs) influences a broad
repertoire of physiological processes, many of which are aberrantly controlled in tumor cells …
repertoire of physiological processes, many of which are aberrantly controlled in tumor cells …
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
K Keller, M Jung - Epigenetic Therapy of Cancer: Preclinical Models and …, 2013 - Springer
Histone deacetylases are key enzymes of epigenetic regulation and are therefore involved
in crucial cellular events like transcription, differentiation, apoptosis and cell division. The …
in crucial cellular events like transcription, differentiation, apoptosis and cell division. The …
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
Objective Pancreatic cancer is characterised by invasive tumour spread and early
metastasis formation. During epithelial–mesenchymal transition, loss of the cell adhesion …
metastasis formation. During epithelial–mesenchymal transition, loss of the cell adhesion …
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer-overexpression of HDAC2 and HDAC3 is associated with clinicopathological …
BM Müller, L Jana, A Kasajima, A Lehmann, J Prinzler… - BMC cancer, 2013 - Springer
Background In breast cancer, the role of epigenetic alterations including modifications of the
acetylation status of histones in carcinogenesis has been an important research focus …
acetylation status of histones in carcinogenesis has been an important research focus …
Multiple myeloma therapy: emerging trends and challenges
Simple Summary Multiple myeloma (MM) is a frequent hematological malignancy
characterized by the uncontrolled growth of clonal plasma cells, primarily in the bone …
characterized by the uncontrolled growth of clonal plasma cells, primarily in the bone …
Targeting the DNA Damage Response in OSCC with TP53 Mutations
A Lindemann, H Takahashi, AA Patel… - Journal of dental …, 2018 - journals.sagepub.com
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer worldwide
and in the United States. OSCC remains a major cause of morbidity and mortality in patients …
and in the United States. OSCC remains a major cause of morbidity and mortality in patients …
Histone deacetylases: structural determinants of inhibitor selectivity
C Micelli, G Rastelli - Drug discovery today, 2015 - Elsevier
Highlights•Isoform-selective histone deacetylase inhibitors are highly desirable.•Crystal
structure information provides important insights into inhibitor selectivity.•We review the …
structure information provides important insights into inhibitor selectivity.•We review the …